10 insiders reported 46 Form 4 transactions for Vera Therapeutics, Inc. (VERA) over the past 18 months (most recent 2026-06-24). Recent activity: Fordyce Marshall (PRESIDENT AND CEO) Sell 18,412 shares, Fordyce Marshall (PRESIDENT AND CEO) Sell 88 shares, Fordyce Marshall (PRESIDENT AND CEO) Sell 14,219 shares, Fordyce Marshall (PRESIDENT AND CEO) Sell 4,281 shares, Fordyce Marshall (PRESIDENT AND CEO) Sell 14,130 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,412 | $698,387 |
| 2026-06-24 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 88 | $3,382 |
| 2026-05-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14,219 | $520,978 |
| 2026-05-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 4,281 | $158,769 |
| 2026-04-15 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14,130 | $616,985 |
| 2026-04-15 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 7,921 | $353,106 |
| 2026-04-15 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 900 | $40,960 |
| 2026-03-25 | Wright-Mitchell Jane | Chief Legal Officer | Buy | 42,403 | $0 |
| 2026-03-16 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Buy | 10,000 | $39,400 |
| 2026-02-25 | Skelton Laurence Matthew | Chief Commercial Officer | Sell | 1,582 | $66,412 |
| 2026-02-25 | JOHNSON DAVID LEE | Chief Operating Officer | Sell | 2,579 | $108,266 |
| 2026-02-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 16,925 | $710,512 |
| 2026-02-25 | Grant Sean | CHIEF FINANCIAL OFFICER | Sell | 4,949 | $207,759 |
| 2026-02-25 | Turner William D. | Chief Regulatory Officer | Sell | 2,187 | $91,810 |
| 2026-02-25 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $130,852 |
| 2026-02-25 | Brenner Robert | Chief Medical Officer | Sell | 2,151 | $90,299 |
| 2026-02-06 | Fordyce Marshall | PRESIDENT AND CEO | Buy | 68,800 | $0 |
| 2026-02-06 | JOHNSON DAVID LEE | Chief Operating Officer | Buy | 20,000 | $0 |
| 2026-02-06 | Grant Sean | CHIEF FINANCIAL OFFICER | Buy | 25,000 | $0 |
| 2026-02-06 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Buy | 10,000 | $0 |
| 2026-02-06 | Skelton Laurence Matthew | Chief Commercial Officer | Buy | 20,000 | $0 |
| 2026-02-06 | Turner William D. | Chief Regulatory Officer | Buy | 25,000 | $0 |
| 2026-02-06 | Brenner Robert | Chief Medical Officer | Buy | 25,000 | $0 |
| 2025-12-17 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $500,800 |
| 2025-12-17 | Turner William D. | Chief Regulatory Officer | Buy | 10,000 | $155,300 |
Source: SEC Form 4 filings · as of 2026-06-24